Come up with a name for your new list and we'll add to it:
Calimmune was acquired by
CSL Behring LLC on August 28, 2017.
Calimmune is a clinical-stage biotechnology company focused on developing novel gene therapies that have the potential to improve and protect the lives of patients by enhancing their immune systems. C…